Sangamo Therapeutics
2 known investors
Sangamo is a genomic medicine company using its proprietary zinc finger technology to develop gene therapies aimed at curing severe diseases, with a focus on neurology and rare disorders. Its pipeline covers indications such as small fiber neuropathy, prion disease, Fabry disease, and hemophilia A, including programs partnered with pharmaceutical companies.
BiotechMedical Devices
Investors Β· 2
Frequently asked questions
- What does Sangamo Therapeutics do?
- Sangamo is a genomic medicine company using its proprietary zinc finger technology to develop gene therapies aimed at curing severe diseases, with a focus on neurology and rare disorders. Its pipeline covers indications such as small fiber neuropathy, prion disease, Fabry disease, and hemophilia A, including programs partnered with pharmaceutical companies.
- Who are Sangamo Therapeutics's investors?
- Sangamo Therapeutics's investors include California Technology Ventures, Ridgeback Capital.